Cardiology Clinical Research

Clinical Research Studies in Cardiology

A randomized, double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (Victorion-2 PREVENT)

Learn more at Clinicaltrials.gov

Principal Investigator: Drew Baldwin, MD
Status: Enrolling
 

DELIVER INSIGHTS IN HYPERTROPHIC CARDIOMYOPATHY AND OBSERVATIONAL OUTCOMES IN REAL WORLD (DISCOVER-HCM): UNITED STATES PROSPECTIVE REGISTRY STUDY

Learn more at Clinicaltrials.gov

Principal Investigator: Mariko Harper, MD 
Status: Enrolling

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP II TR)A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCA

A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation.

Learn more at Clinicaltrials.gov

Principal Investigator: Ming Zhang, MD
Status: Enrolling

Edwards Transcatheter Valve Tricuspid Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device.

Learn more at Clinicaltrials.gov

Principal Investigator: Ming Zhang, MD
Status: Enrolling

Irrigated Radio Frequency Ablation to Terminate Non-Paroxysmal Atrial Fibrillation (Terminate AF Study)

Learn more at Clinicaltrials.gov

Principal Investigator: Robert Moraca, MD
Status: Enrolling

Percutaneous or Surgical Mitral Valve REpair in PAtients with Primary Mitral Regurgitation whose mitral valve has been determined to be suitable for correction by MV repair surgery.

Learn more at Clinicaltrials.gov

Principal Investigator: Ming Zhang, MD
Status: Enrolling

Post-Approval Study Protocol for Hybrid Convergent of Epicardial RF Ablation and Endocardial Ablation for the Treatment of Symptomatic Long Standing Persistent AF.

Learn more at Clinicaltrials.gov

Principal Investigator: Robert Moraca, MD 
Status: Enrolling

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF) EMPEROR

Learn more at Clinicaltrials.gov

Principal Investigator: Sarah Weiss, MD
Status: Closed to Enrollment

DETERMINE-preserved-Dap0agliflozin EffecT on ExeRcise capacity using 6 MINutE walk test in patients with heart failure with preserved ejection fraction.

Learn more at Clinicaltrials.gov

Principal Investigator: Sarah Weiss, MD
Status: Closed to Enrollment